NXTC – Nextcure Inc
NXTC — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
48.67
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
0.04
EPS Last/This Y
12.19
EPS This/Next Y
0.4
Price
5.88
Target Price
20
Analyst Recom
1
Performance Q
-42.63
Upside
-11,528.9%
Beta
1.32
Ticker: NXTC
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-07-13 | NXTC | 2.2 | N/A | N/A | 0 |
| 2026-07-14 | NXTC | 6.41 | N/A | N/A | 0 |
| 2026-07-15 | NXTC | 6.57 | N/A | N/A | 0 |
| 2026-07-16 | NXTC | 6.295 | N/A | N/A | 0 |
| 2026-07-17 | NXTC | 5.98 | N/A | N/A | 0 |
| 2026-07-20 | NXTC | 5.41 | N/A | N/A | 0 |
| 2026-07-21 | NXTC | 5.12 | N/A | N/A | 0 |
| 2026-07-22 | NXTC | 4.41 | N/A | N/A | 0 |
| 2026-07-23 | NXTC | 4.18 | N/A | N/A | 0 |
| 2026-07-24 | NXTC | 4.25 | N/A | N/A | 0 |
| 2026-07-27 | NXTC | 5.13 | N/A | N/A | 0 |
| 2026-07-28 | NXTC | 5.43 | N/A | N/A | 0 |
| 2026-07-29 | NXTC | 5.02 | N/A | N/A | 0 |
| 2026-07-30 | NXTC | 5 | N/A | N/A | 0 |
| 2026-07-31 | NXTC | 4.14 | N/A | N/A | 0 |
| 2026-08-03 | NXTC | 4.28 | N/A | N/A | 0 |
| 2026-08-04 | NXTC | 5.83 | N/A | N/A | 0 |
| 2026-08-05 | NXTC | 5.27 | N/A | N/A | 0 |
| 2026-08-07 | NXTC | 5.91 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-07-13 | NXTC | 2.18 | 83.0 | - | -7.32 |
| 2026-07-14 | NXTC | 6.45 | 83.0 | - | -7.32 |
| 2026-07-15 | NXTC | 6.56 | 83.0 | - | -7.32 |
| 2026-07-16 | NXTC | 6.28 | 83.0 | - | -7.32 |
| 2026-07-17 | NXTC | 6.00 | 83.0 | - | -7.46 |
| 2026-07-20 | NXTC | 5.45 | 83.0 | - | -7.46 |
| 2026-07-21 | NXTC | 5.12 | 83.0 | - | -7.46 |
| 2026-07-22 | NXTC | 4.40 | 83.0 | - | -7.46 |
| 2026-07-23 | NXTC | 4.19 | 83.0 | - | -7.46 |
| 2026-07-24 | NXTC | 4.24 | 83.0 | - | -7.46 |
| 2026-07-27 | NXTC | 5.13 | 83.0 | - | -7.46 |
| 2026-07-28 | NXTC | 5.47 | 83.0 | - | -7.46 |
| 2026-07-29 | NXTC | 5.05 | 83.0 | - | -7.46 |
| 2026-07-30 | NXTC | 5.05 | 83.0 | - | -7.46 |
| 2026-07-31 | NXTC | 4.10 | 83.0 | - | -7.46 |
| 2026-08-03 | NXTC | 4.40 | 83.0 | - | -7.46 |
| 2026-08-04 | NXTC | 4.40 | 83.0 | - | -7.46 |
| 2026-08-05 | NXTC | 5.28 | 83.0 | - | -7.46 |
| 2026-08-06 | NXTC | 5.52 | 83.0 | - | -7.46 |
| 2026-08-07 | NXTC | 5.88 | 83.0 | - | -7.46 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-07-13 | NXTC | 0.00 | 7.39 | 6.69 |
| 2026-07-14 | NXTC | 0.00 | 7.39 | 6.69 |
| 2026-07-15 | NXTC | 0.00 | 7.39 | 6.69 |
| 2026-07-16 | NXTC | 0.00 | 7.39 | 6.69 |
| 2026-07-17 | NXTC | 0.00 | 7.39 | 6.69 |
| 2026-07-20 | NXTC | 0.00 | 6.51 | 5.94 |
| 2026-07-21 | NXTC | 0.00 | 6.51 | 5.94 |
| 2026-07-22 | NXTC | 0.00 | 6.51 | 5.94 |
| 2026-07-23 | NXTC | 0.00 | 6.51 | 5.94 |
| 2026-07-24 | NXTC | 0.00 | 6.51 | 5.94 |
| 2026-07-27 | NXTC | 0.00 | 6.51 | 49.58 |
| 2026-07-28 | NXTC | 0.00 | 6.51 | 49.58 |
| 2026-07-29 | NXTC | 0.00 | 6.51 | 49.58 |
| 2026-07-30 | NXTC | 1.28 | 6.51 | 49.58 |
| 2026-07-31 | NXTC | 1.28 | 6.51 | 49.58 |
| 2026-08-03 | NXTC | 1.28 | 6.51 | 49.58 |
| 2026-08-04 | NXTC | 33.07 | 6.51 | 48.67 |
| 2026-08-05 | NXTC | 34.73 | 6.51 | 48.67 |
| 2026-08-06 | NXTC | 34.71 | 6.51 | 48.67 |
| 2026-08-07 | NXTC | 34.72 | 6.51 | 48.67 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.87
Avg. EPS Est. Current Quarter
-1.92
Avg. EPS Est. Next Quarter
-1.83
Insider Transactions
34.72
Institutional Transactions
6.51
Beta
1.32
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
3
Growth Score
19
Sentiment Score
91
Actual DrawDown %
94.7
Max Drawdown 5-Year %
-98.5
Target Price
20
P/E
Forward P/E
PEG
P/S
P/B
0.79
P/Free Cash Flow
EPS
-19.07
Average EPS Est. Cur. Y
-7.46
EPS Next Y. (Est.)
-7.07
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.12
Return on Equity vs Sector %
-100
Return on Equity vs Industry %
-100
EPS 1 7Days Diff
-0.1
EPS 1 30Days Diff
-0.14
EBIT Estimation
◆
NXTC
Healthcare
$5.84
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
59.8
Range 1M
48.3%
Sup Dist
12.3%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
62.4%
EPS NY
19.5%
52W%
28.6%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+242.5% upside
Upside
+242.5%
Quality
3
NXTC — P/E HistoricalBiotechnology
NextCure, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 40
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer's disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company also develop SIM0505, a novel antibody-drug conjugate (ADC) targeting CDH6 (cadherin-6 or K-cadherin) for the treatment of solid tumors. The company was incorporated in 2015 and is headquartered in Beltsville, Maryland.
NXTC
Latest News
—
Caricamento notizie per NXTC…
stock quote shares NXTC – Nextcure Inc Stock Price stock today
news today NXTC – Nextcure Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch NXTC – Nextcure Inc yahoo finance google finance
stock history NXTC – Nextcure Inc invest stock market
stock prices NXTC premarket after hours
ticker NXTC fair value insiders trading